We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+28.39%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$144M
AUM Growth
+$24.9M
Cap. Flow
-$2.1M
Cap. Flow %
-1.45%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
1
Bicycle Therapeutics
BCYC
$303M
$30.1M 20.91%
1,915,274
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$26.9M 18.64%
449,951
– –
MSON
3
DELISTED
Misonix Inc
MSON
$23M 15.96%
1,695,969
– –
TECX
4
Tectonic Therapeutic
TECX
$717M
$21.6M 14.96%
103,010
– –
KALV
5
DELISTED
KalVista Pharmaceuticals
KALV
$20.8M 14.43%
1,719,576
– –
STRO icon
6
Sutro Biopharma
STRO
$353M
$14.2M 9.82%
182,454
– –
XFOR icon
7
X4 Pharmaceuticals
XFOR
$419M
$2.9M 2.01%
10,383
– –
OCUL icon
8
Ocular Therapeutix
OCUL
$2.38B
$2.6M 1.8%
312,068
-316,168
-50% -$2.1M
ATXS
9
DELISTED
Astria Therapeutics
ATXS
$1.84M 1.27%
47,628
– –
ASXC
10
DELISTED
Asensus Surgical, Inc.
ASXC
$276K 0.19%
510,142
– –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q2 2020 Portfolio in Review

As of Q2 2020, SV Health Investors held 10 positions worth $144M, up 21% from $119M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 0%. SV Health Investors opened no new positions and made no exits, leaving the 10-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SV Health Investors's biggest Q2 2020 reduction was Ocular Therapeutix, cutting an estimated $2.1M.
  • SV Health Investors's ten largest holdings make up 100% of its $144M portfolio in Q2 2020.
  • SV Health Investors opened 0 new positions and closed 0 in Q2 2020.
  • SV Health Investors's portfolio value rose 21% quarter-over-quarter to $144M.

Based on SV Health Investors's 13F filing for Q2 2020, filed 14 Aug 2020.